back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2017-12-12 Tx date 2017-12-07 |
$AQS
Aequus Pharmaceuticals Inc. |
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+452,941 vol |
452,941 | |
| Filed 2017-12-12 Tx date 2015-02-18 |
$AQS
Aequus Pharmaceuticals Inc. |
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-05-06 Tx date 2016-05-03 |
$AQS
Aequus Pharmaceuticals Inc. |
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,369
+3,000 vol $0.4566 each |
6,076,458 | |
| Filed 2016-05-06 Tx date 2016-05-04 |
$AQS
Aequus Pharmaceuticals Inc. |
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,125
+2,500 vol $0.45 each |
6,078,958 | |
| Filed 2016-04-01 Tx date 2016-03-31 |
$AQS
Aequus Pharmaceuticals Inc. |
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,225
+2,500 vol $0.49 each |
6,064,958 | |
| Filed 2016-04-01 Tx date 2016-04-01 |
$AQS
Aequus Pharmaceuticals Inc. |
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,530
+3,000 vol $0.51 each |
6,073,458 | |
| Filed 2016-04-01 Tx date 2016-04-01 |
$AQS
Aequus Pharmaceuticals Inc. |
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,855
+3,500 vol $0.53 each |
6,070,458 | |
| Filed 2016-04-01 Tx date 2016-03-31 |
$AQS
Aequus Pharmaceuticals Inc. |
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,020
+2,000 vol $0.51 each |
6,066,958 | |
| Filed 2016-04-01 Tx date 2016-03-29 |
$AQS
Aequus Pharmaceuticals Inc. |
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$495.00
+1,000 vol $0.495 each |
6,062,458 | |
| Filed 2016-04-01 Tx date 2016-03-29 |
$AQS
Aequus Pharmaceuticals Inc. |
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,187
+2,500 vol $0.475 each |
6,061,458 | |
| Filed 2016-04-01 Tx date 2016-03-29 |
$AQS
Aequus Pharmaceuticals Inc. |
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,525
+7,500 vol $0.47 each |
6,058,958 | |
| Filed 2016-03-21 Tx date 2016-03-17 |
$AQS
Aequus Pharmaceuticals Inc. |
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$41,979
+83,958 vol $0.50 each |
6,051,458 | |
| Filed 2016-03-21 Tx date 2016-03-17 |
$AQS
Aequus Pharmaceuticals Inc. |
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,425
+3,000 vol $0.475 each |
5,967,500 | |
| Filed 2016-03-21 Tx date 2016-03-16 |
$AQS
Aequus Pharmaceuticals Inc. |
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,520
+12,000 vol $0.46 each |
5,964,500 | |
| Filed 2016-01-15 Tx date 2016-01-14 |
$AQS
Aequus Pharmaceuticals Inc. |
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,000
+10,000 vol $0.50 each |
5,952,500 | |
| Filed 2016-01-14 Tx date 2016-01-14 |
$AQS
Aequus Pharmaceuticals Inc. |
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,650
+5,000 vol $0.53 each |
5,942,500 | |
| Filed 2016-01-14 Tx date 2016-01-14 |
$AQS
Aequus Pharmaceuticals Inc. |
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,700
+5,000 vol $0.54 each |
5,937,500 | |
| Filed 2015-12-18 Tx date 2015-12-11 |
$AQS
Aequus Pharmaceuticals Inc. |
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,734
+27,000 vol $0.4346 each |
5,932,500 | |
| Filed 2015-12-18 Tx date 2015-12-11 |
$AQS
Aequus Pharmaceuticals Inc. |
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,734
+27,000 vol $0.4346 each |
||
| Filed 2015-11-16 Tx date 2015-11-12 |
$AQS
Aequus Pharmaceuticals Inc. |
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,500
+5,000 vol $0.50 each |
5,905,500 | |
| Filed 2015-11-06 Tx date 2015-11-04 |
$AQS
Aequus Pharmaceuticals Inc. |
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,000
+8,000 vol $0.50 each |
5,900,500 | |
| Filed 2015-11-06 Tx date 2015-11-03 |
$AQS
Aequus Pharmaceuticals Inc. |
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,000
+10,000 vol $0.50 each |
5,892,500 | |
| Filed 2015-09-20 Tx date 2015-09-16 |
$AQS
Aequus Pharmaceuticals Inc. |
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$265.00
+500 vol $0.53 each |
5,882,500 | |
| Filed 2015-09-20 Tx date 2015-09-16 |
$AQS
Aequus Pharmaceuticals Inc. |
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,480
+12,000 vol $0.54 each |
5,882,000 | |
| Filed 2015-06-18 Tx date 2015-06-16 |
$AQS
Aequus Pharmaceuticals Inc. |
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,450
+5,000 vol $0.49 each |
5,870,000 | |
| Filed 2015-06-18 Tx date 2015-06-16 |
$AQS
Aequus Pharmaceuticals Inc. |
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,500
+5,000 vol $0.50 each |
5,865,000 | |
| Filed 2015-06-15 Tx date 2015-06-15 |
$AQS
Aequus Pharmaceuticals Inc. |
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,050
+11,000 vol $0.55 each |
5,855,000 | |
| Filed 2015-06-15 Tx date 2015-06-15 |
$AQS
Aequus Pharmaceuticals Inc. |
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,849
+5,000 vol $0.57 each |
5,860,000 | |
| Filed 2015-06-15 Tx date 2015-06-15 |
$AQS
Aequus Pharmaceuticals Inc. |
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,860
+9,000 vol $0.54 each |
5,844,000 | |
| Filed 2015-06-12 Tx date 2015-05-15 |
$AQS
Aequus Pharmaceuticals Inc. |
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,994
+3,500 vol $0.57 each |
5,818,500 | |
| Filed 2015-06-12 Tx date 2015-06-11 |
$AQS
Aequus Pharmaceuticals Inc. |
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,699
+10,000 vol $0.57 each |
5,835,000 | |
| Filed 2015-06-12 Tx date 2015-05-21 |
$AQS
Aequus Pharmaceuticals Inc. |
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,704
+6,500 vol $0.57 each |
5,825,000 | |
| Filed 2015-05-14 Tx date 2015-05-13 |
$AQS
Aequus Pharmaceuticals Inc. |
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,130
+7,000 vol $0.59 each |
5,815,000 | |
| Filed 2015-05-11 Tx date 2015-05-04 |
$AQS
Aequus Pharmaceuticals Inc. |
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,709
+3,000 vol $0.57 each |
5,804,000 | |
| Filed 2015-05-11 Tx date 2015-05-08 |
$AQS
Aequus Pharmaceuticals Inc. |
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,400
+4,000 vol $0.60 each |
5,808,000 | |
| Filed 2015-05-11 Tx date 2015-05-01 |
$AQS
Aequus Pharmaceuticals Inc. |
Plakogiannis, Fotios
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$600.00
+1,000 vol $0.60 each |
5,801,000 |